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Abstract 
 
Cardiovascular disease is the major cause of death and disability in America. The burden 
of cardiovascular disease is higher in elders than in younger populations, presumably 
because of life-long exposure to risk factors such as hypertension, smoking, abnormal 
blood lipids, lack of exercise, and/or obesity. Many assume that it is too late to attempt to 
modify risk factors in elders because behavior is so difficult to change. The purpose of 
this article is to argue that cardiovascular risk factor modification is effective in elders 
and should be vigorously pursued for the good of individuals, families, communities, and 
societies. 
 
Key Words: cardiovascular disease, elders, hypertension, smoking, lipids, exercise, 
obesity.
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Cardiovascular disease (CVD) is the primary cause of death and disability among men 
and women in the United States and the world. According to the American Heart 
Association (1999), 58,800,000 Americans (21.6% of the population) have one or more 
forms of CVD. Elders, defined as individuals age 65 years or older, comprise almost 13% 
of our population (United States. Census Bureau, 1999). Yet, CVD is disproportionately 
represented in this group; 65% of the CVD hospitalizations in 1996 were in elders and 
about 84% of the deaths from CVD occurred in this age group (American Heart 
Association, 1999). Obviously, CVD is a disease of elders. 
 Cardiovascular disease significantly affects quality of life and successful aging. 
Individuals, families, communities, and society as a whole feel the burden of CVD. For 
example, Medicare spent $24.6 billion on hospitalizations for CVD in 1995—almost a 
third of their expenditures (American Heart Association, 1999). This amount, although 
enormous, fails to account for outpatient testing, provider visits, pharmaceutical 
expenses, and lost days of work among patients and family members.  
Many of the factors causing CVD are known and can be modified effectively 
through life-style changes and therapeutic means. Some clinicians remain doubtful, 
however, that decades of exposure to cardiovascular risk factors can be reversed by 
changes begun in later life. The purpose of this article is to argue that CVD risk factor 
modification is effective in elders but is pursued less vigorously in older people than in 
younger individuals. This preferential behavior may be related to the fact that individuals 
over age 65 have been routinely excluded from clinical and epidemiological trials. Thus, 
recommendations for risk factor modification in elders often must be extrapolated from 
trials conducted in younger populations.  
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Overview of Cardiovascular Disease 
Cardiovascular disease refers to various diseases of the heart and blood vessels but there 
is no universally accepted definition of the term CVD. The American Heart Association 
(1999) defines CVD as including: hypertension (HTN) or high blood pressure, coronary 
heart disease (also called coronary artery disease), angina pectoris (transient chest pain 
associated with inadequate blood supply to the heart muscle), myocardial infarction (i.e., 
heart attack), stroke, rheumatic heart disease, congenital cardiovascular defects, and heart 
failure.  
 By far, the most common form of CVD is HTN, which affects fifty million 
Americans, most of whom are elderly (Joint National Committee-VI, 1997). Heart failure 
is also a prevalent form of CVD. Almost five million people in the U.S. have heart failure 
and it is the single most common cause of hospitalization in elders (Cohn, Abraham, 
Levine, Pina & Silver, 1999). 
 Most of the diseases grouped under the heading CVD are interrelated (Figure 1). 
For example, HTN is a major, independent risk factor for both coronary heart disease and 
heart failure (Kannel, 1996). Coronary heart disease is the primary etiology of heart 
failure, although a variety of other factors also cause heart failure (e.g., heart valve 
defects caused by diseases such as rheumatic fever or infection, primary disease of the 
heart muscle known as cardiomyopathy, and congenital heart disease). 
 Much CVD is caused by atheromatous plaque build-up on the intima or inner 
layer of the arterial wall. Coronary heart disease, angina pectoris, and myocardial 
infarction are primarily atherosclerotic in etiology. Likewise, hypertension and stroke are 
often manifestations of the same process in arteries of the body and the brain. Thus, a 
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major decline in CVD can be accomplished through modification of the major risks 
known to be associated with atherosclerosis: HTN, smoking, abnormal blood lipids, 
physical inactivity, and obesity. People often focus on the need to reduce their stresses 
(Fielding, 1987) although the link between CVD and stress remains elusive. Currently, 
stress is not classified as a major CVD risk factor (American Heart Association, 1999).  
Cardiovascular Disease Risk Factors in Elders 
As people age, they are even more susceptible to the onset of CVD than they were 
as younger adults. Some risk factors for CVD, such as HTN, are more likely to occur in 
older adults while other risk factors, such as smoking and sedentary lifestyle, are 
behavioral risks whose effects may accumulate over many years to increase the risk of 
CVD as a person ages. For example, body weight may increase over time and result in 
obesity if an older adult does not continue to pursue an active lifestyle. Older adults who 
have a combination of risk factors may be particularly susceptible to CVD. For example, 
in one study, researchers found that non-smoking older adults with low cholesterol, low 
blood pressure and no cardiac abnormalities had fewer cardiac events than did those 
without this low-risk profile (Daviglus, et al., 1998). Obviously, the etiology of CVD is 
complex and often the result of an accumulation of many seemingly minor transgressions 
that we all allow ourselves.  
 Because the risk of CVD is high if an elder has a combination of risks, the 
mitigation of even one factor should have considerable benefit in the prevention of CVD. 
There is general consensus that reducing CVD risk factors is beneficial for children, 
adolescents, and young adults but aggressive risk factor reduction in elders is 
controversial for three reasons. First, there is debate about the need for aggressive 
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intervention because some risk factors, such as hyperlipidemia, are less predictive of 
CVD as a person ages (Kannel, 1997). Second, some believe that efforts at risk factor 
reduction in elderly persons are not good for society. Smoking cessation programs, for 
example, can increase health care costs by increasing life span (Barendregt, Bonneux, & 
van der Maas, 1997). Third, there is controversy about the effectiveness of such strategies 
in an older, “set-in-their-ways” population. Can elders be helped to modify their CVD 
risks or are we simply wasting our time?  
 The remainder of this article addresses the third issue. Each of the major risk 
factors (HTN, smoking, abnormal blood lipids, sedentary lifestyle, obesity and the 
commonly cited “stress” factor) is discussed with a focus on the research evidence that 
CVD risk reduction strategies that are useful for younger persons are also efficacious for 
elders. Though other factors (e.g., diabetes, insulin resistance, homocysteinemia), are also 
important contributors to CVD, only the major risk factors modifiable through life-style 
change are addressed in this article. 
Hypertension  
 Hypertension is the most important risk factor for CVD in the elderly (National 
High Blood Pressure Education Program Working Group, 1994). Yet, the treatment of 
HTN has been plagued by an attitude of “therapeutic nihilism” that remains difficult to 
overcome (Moser, 1997). Less than a decade ago there was still uncertainty about 
whether to treat HTN in elders once it was diagnosed (Cushman & Black, 1999). 
Erroneously, elders were expected to experience a 10 mm Hg increase in systolic blood 
pressure (BP) with each decade of life, and a BP less than 220/100 mm Hg was termed 
“mild benign HTN” (Friedberg, 1966). Health care providers today consider a systolic BP 
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of 140 mm Hg or higher and/or diastolic BP of 90 mm Hg or higher as clinically 
significant HTN that requires treatment. Isolated systolic HTN is common and 
particularly malicious (Kannel, 1996). Current recommendations suggest that a BP below 
120/80 is ideal (JNC-VI, 1997), although such a goal is difficult to achieve in elders 
because of the anatomic and physiologic changes that occur with aging (Moser, 1992). 
 Hypertension is extremely common among elders; 57.3% of men and 60.8% of 
women between the ages 65 and 74 have documented HTN (American Heart 
Association, 1999). In individuals 75 years or older, 64.2% of men and 77.3% of women 
have BP higher than 140/90. Even a relatively small increase in systolic or diastolic BP is 
associated with an increased risk of stroke, myocardial infarction, sudden cardiac death, 
coronary heart disease, heart failure, renal disease, and all-cause mortality. Treatment of 
HTN in elders effectively reduces the risk for CVD morbidity and mortality, including 
stroke (Cushman & Black, 1999; Moser, 1992). The benefits of treatment for HTN have 
been demonstrated in individuals with diastolic HTN up to age 80 and with systolic HTN 
up to age 90 (Rich, 1999). 
 Recent guidelines from the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (1997) cite the importance of lifestyle 
modification in the treatment of HTN. Weight control is the most effective 
nonpharmacologic therapy available. In addition to weight control, the authors of the 
guidelines advocate aerobic physical activity and dietary modifications (e.g., limiting 
alcohol, reducing sodium intake, and maintaining adequate potassium intake). A 
reduction in dietary saturated fats and cholesterol is also recommended, although the 
direct effect of these dietary changes on uncomplicated HTN is unknown. It is possible 
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that a reduction of dietary fats may assist in weight control that, in turn, should lower 
blood pressure. However, there are no data that demonstrate a direct relationship between 
dietary fat intake and HTN in individuals of normal body weight. 
 In spite of the prevalence of HTN, it is often inadequately treated. Current 
estimates indicate that only 27.4% of known hypertensives have good control of their BP 
(i.e., <140/90 mm/Hg) (Burt, et al., 1995). The treatment of elders with HTN is 
particularly problematic. In a survey of general practitioners in the United Kingdom, 
Coppola and colleagues (1997) found that the thresholds for drug treatment of HTN 
increased with patient age. In that study, only 68% of systolic HTN, 23% of diastolic 
HTN, and 9% of isolated systolic HTN was treated in patients between 70 and 79 years 
of age. Likewise, a study in the U.S. showed that only 7% of elderly HTN patients 
enrolled in a large health maintenance organization had achieved a BP <140/90 (Barker, 
Mullooly & Linton, 1998). Berlowitz et al (1998) demonstrated that poor control of BP in 
a sample of elderly male hypertensives was due to lack of aggressiveness in therapy 
rather than failure of the treatment program. In that study, those patients who received 
more intensive medical therapy achieved better BP control, suggesting that the issue was 
physician attention rather than patient compliance.  
These results suggest that aggressive therapy for HTN can effectively lower blood 
pressure. Yet, many elders with HTN do not receive adequate treatment. In order to 
achieve a reduction in the prevalence of HTN in older adults, and thus prevent the 
incidence of CVD in this population, it may be necessary to change the practice of health 
care providers rather than the behavior of patients.  
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Smoking 
 Cigarette smoking caused 418,690 of the two million U.S. deaths in 1990. The 
percentage of total CVD deaths attributable to smoking is about 29% (Center for Disease 
Control and Prevention 1993; Jonas, et al, 1992) and many who die of CVD are elders 
who began smoking many years before the risks of smoking were widely known. 
Currently, an estimated 14.9% of men and 11.5% of women over age 65 are smokers 
(American Heart Association, 1999). 
Smoking is a well-established risk factor for atherosclerosis that often leads to 
coronary heart disease, stroke, and myocardial infarction (Rigotti & Pasternak, 1996). 
Smoking also contributes to hypertension, one of the primary causes of atherosclerotic 
CVD. In addition, research shows that cigarette smoke interacts with the metabolism of 
some drugs used to treat atherosclerosis a factor of particular importance to elders, who 
often take multiple medications daily (Berg, 1999). 
 Smoking cessation at any age has been shown to dramatically affect 
cardiovascular health.  Reduced cardiovascular mortality can be demonstrated within a 
year of cessation (Hall, 1997).  Further, there may be a benefit to elderly individuals in 
quitting smoking even after cardiovascular disease has occurred. A longitudinal study of 
patients who had undergone coronary artery revascularization showed that persistent 
smokers were 1.44 times more likely to die than those who quit smoking after the surgery 
(Hasdai, Garratt, Grill, Lerman, & Holmes, 1997). 
 The decision to quit smoking has health benefits for a smoker of any age and a 
variety of successful programs have been developed to help smokers quit (Richmond, 
1999).  According to Prochaska, DiClemente, and Norcross (1992), ending an addictive 
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behavior such as smoking requires that the smoker be ready to take action to end the 
habit.  Rather than talking about quitting (contemplation stage), or simply reducing the 
number of cigarettes smoked (preparation stage), a smoker must make the decision to quit 
and follow through on that decision (action stage). 
 Like many younger smokers, elderly persons take action to quit smoking if they 
have experienced symptoms that they attribute to smoking rather than to age (Clark, 
Hogan, Kviz, & Prochaska, 1999). Hospitalization also prompts elders to quit smoking 
and several researchers have reported successful smoking cessation interventions in post-
surgical and hospitalized elders. For example, counseling by nurses in a thoracic surgery 
unit led 40% of patients to quit (Di Tullio et al., 1991; Wewers, Jenkins, & Mignery, 
1997). In another study, 15% of surgery patients at a Veteran’s Administration hospital 
quit smoking within twelve weeks of receiving in-hospital counseling, nicotine 
replacement, and follow-up telephone calls compared to 8% in a control group (Simon, 
Solkowitz, Carmody, & Browner, 1997). 
Outpatient smoking cessation programs for elders have also been successful. For 
example, at Mayo Medical Center, 613 patients aged 65-82 received a nicotine 
dependence consultation that resulted in 24.8% of the patients abstaining from smoking 
(Dale et al., 1997).  Researchers in another study found that a brief counseling session in 
a physician’s office resulted in a 15% smoking cessation rate among a group of smokers 
aged 50-74, compared to an 8% cessation rate in a group that did not receive counseling 
(Morgan et al., 1996).   
Clearly, elderly smokers can quit smoking when they are ready to do so. Smoking 
cessation programs can be successful if they are targeted at elders who are ready to take 
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action because they believe their medical conditions are caused by smoking. Other 
stimuli that lead elders to quit smoking need to be identified in future research. Because 
smoking cessation can reduce the risk of death by CVD in as short a time as one year 
after an elder stops smoking, quitting smoking may be one of the best behavioral changes 
an elder can make to reduce the risk of CVD. 
Abnormal Blood Lipids 
  Abnormal lipids have been known to be a risk factor for atherosclerosis and CVD  
for over three decades. Yet, efforts to control lipid levels in elders have been irresolute, 
probably for three reasons. First, it is difficult to predict who will develop abnormal 
blood lipids. Some people develop an elevated cholesterol level in spite of adhering to a 
relatively healthy diet. Second, the strength of the association between lipid levels and 
coronary heart disease is attenuated with age (Kannel, 1997). For example, lipid levels in 
men peak in middle age and then decline (Johnson, Rifkind, Sempos et al, 1993). This 
observation may have convinced many practitioners that elevated cholesterol does not 
require aggressive treatment. In reality, LDL:HDL ratio is a strong predictor of CVD in 
the elderly. Elevated triglycerides is an independent risk factor in elderly women but not 
in elderly men (La Rosa, 1997). Third, although elders respond as well to lipid lowering 
therapy as do younger individuals, few studies have been conducted to demonstrate 
outcomes of therapy (e.g., lower mortality). In fact, no studies of lipid lowering therapy 
have included participants over age 80 (Rich, 1999). The largest trial of lipid lowering 
therapy to date (West of Scotland Coronary Prevention Study (Shepherd, Cobbe, Ford, et 
al, 1995) excluded individuals over age 65. 
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 Abnormal blood lipids are diagnosed by assessment of total cholesterol, low and 
high density lipoproteins (LDL and HDL), and triglycerides. A desirable lipid profile in a 
low-risk individual without known CVD includes a total cholesterol <200 mg/dL, an 
LDL <160 mg/dL, an HDL >45 mg/dL in men and >55 mg/dL in women, and 
triglycerides <200 mg/dL (NCEP, 1994). A prudent, “Step I” (<30% fat, <10% saturated 
fats, <300 mg/d cholesterol) diet is recommended for low risk elders with any lipid 
abnormality (Winston, et al, 2000).  
 Many elders are high risk (e.g., known CVD, multiple risk factors) and the lipid 
profile goals are more strict in this population. For example, total cholesterol <180 
mg/dL, LDL <100 mg/dL, and triglycerides <130 mg/dL are the goals (National 
cholesterol Education Program, 1994). To achieve these goals, the Society of Geriatric 
Cardiology recommends six months on a stricter “Step II” (<30% fat, <7% saturated fats, 
<200 mg/d cholesterol) diet. The Step II diet is often effective in lowering serum lipids 
(Winston et al, 2000). For example, Duell (1998) found that a diet in which 
polyunsaturated fats (e.g., canola oil) replaced saturated fats (e.g., lard) and in which 
dietary fiber (e.g., bran, legumes) was increased resulted in lower total cholesterol, LDL 
cholesterol, and triglycerides. The addition of exercise can help raise HDL cholesterol, a 
desirable effect (Gulanick & Cofer, 2000). However, lifestyle changes such as diet are 
often not enough to achieve lipid goals.  
Failing achievement of lipid goals, lipid-lowering agents remain the most 
effective approach. These agents have been shown to lower CVD outcomes in the general 
population. Many physicians limit such medications to those elders with very high 
cholesterol levels and/or multiple other risk factors because of the lack of clinical trial 
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data demonstrating effectiveness in this population. There is growing consensus, 
however, that intensive lipid lowering therapy is justified in everyone with known CVD, 
regardless of age (Grundy, 1998). A somewhat more conservative but individualized 
approach is advocated for those individuals without evidence of CVD. 
 A combined treatment approach to abnormal blood lipids is most effective, 
regardless of age. Allison and colleagues (1999) tested an aggressive nurse-run 
secondary-prevention intervention that included diet, exercise, and lipid-lowering 
medications in a sample of elderly individuals who had completed cardiac rehabilitation. 
Pharmacotherapy was most effective in achieving LDL goals but 35% of patients reached 
their lipid goals with a combination of exercise, dietary compliance, and weight loss.  
Inactivity 
 A sedentary lifestyle is a major risk factor for CVD in the general population. A 
meta-analysis of epidemiological studies suggested that lack of leisure-time activity may 
be the most important risk factor for CVD, accounting for 22-39% of preventable deaths 
from CVD, compared to 10-33% for smoking, 9-21% for high total cholesterol, 6-15% 
for hypertension, and 3-6% for obesity (Haapanen-Niemi,Vuori, & Pasanen, 1999).  
Fortunately, the key word in the above statistic is “preventable”. Of the major risk factors 
for CVD, sedentary lifestyle is perhaps the easiest to change, by increasing the physical 
activity levels of people of all ages, including elders. 
 Though children and young adults may be physically active without needing to 
plan regular exercise sessions, older adults are relatively less active. Nearly 40% of 
people over age 55 report that they do not engage in any leisure-time physical activity 
(American Heart Association, 1999). In general, elderly women are more sedentary than 
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elderly men (Berger, 1999). Therefore, elders may need to plan regular exercise activities 
in order to maintain cardiovascular fitness. Studies have shown that elders who exercise 
not only reduce the occurrence of new onset diagnoses of CVD (Posner et al., 1990), but 
also improve balance, increase functional ability, reduce falls, increase mental 
processing, and reduce musculoskeletal stiffness and bone loss (Elward & Larson, 1992). 
Almost any exercise that gets an elder moving is useful. Therefore, the American Heart 
Association includes a variety of activities in its exercise recommendations for older 
adults, including gardening, shopping, dancing, and housework (1999).  
 Although engaging in any activity, such as housework or shopping, is better than 
living a purely sedentary lifestyle, research shows that a progressive program of planned 
exercise will reap even more cardiovascular benefits, especially for elders. Walking may 
be an ideal exercise for older adults, because it is safe, cheap, and easy. If an older adult 
gradually increases walking to an aerobic level, cardiovascular fitness will be improved.  
For example, researchers from the Honolulu Heart Program found that elderly men who 
walked more than a mile a day were half as likely to develop CVD than were those who 
walked less than a quarter mile a day (Hakim et al., 1999).  
 The health benefits of walking are evident for even the oldest old. One study 
found that women over the age of 90 reduced their resting and working heart rates, 
increased their functional abilities, and improved their morale after a 6-month program of 
twice-weekly walking (Hamdorf & Penhall, 1999). There is no doubt that physical 
activity is important to cardiovascular fitness at any age and is particularly important for 
elders, who tend to become sedentary as they age.  
Obesity 
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 Obesity has reached epidemic proportions in the United States. This risk factor for 
CVD is a particular problem for elders because body weight usually increases as 
individuals age. Obesity is usually measured in terms of body mass index (BMI), 
calculated as weight in kilograms divided by the square of the height in meters (weight / 
height 2). Generally, a BMI of 30 is considered the threshold for defining obesity (Expert 
Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in 
Adults, 1998). High BMI is associated with many adverse health outcomes, including 
CVD, because obesity is directly associated with atherogenic risk factors such as HTN, 
abnormal blood lipids, and glucose intolerance (Kannel, 1997). In fact, an obese person is 
three times more likely to develop HTN than a lean person (Wofford, et al., 1999). One 
study found that men (of all ages) with a BMI >25 but <30 were 5.5 times more likely to 
have at least one additional CVD risk factors than were men with a BMI <25 (Lean, Han, 
& Seidell, 1999). Obese women are also at high risk for CVD. Longitudinal data from the 
Nurses’ Health Study showed that women with a BMI >32 were 4.1 times more likely to 
die of CVD than were women with a BMI <19 (Manson et al., 1995). Though it is 
difficult to specify a body weight that optimizes the risk of CVD, a healthy BMI is about 
23 for men and 21 for women, regardless of age (Kannel, 1997).  
 Obesity is primarily associated with a sedentary lifestyle, and the increasing body 
weight that is usually accepted as a normal part of aging is, in large part, caused by the 
decreasing activity levels of most older adults, especially women (Brownell & Rodin, 
1994; Jensen & Rogers, 1998). Thus, one would expect that increasing physical activity 
would reduce obesity. However, physical activity alone will do little to reduce BMI 
unless caloric intake is also reduced. The desirability of dieting for obese older adults is a 
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controversial subject. On one hand, animal studies have led some to conclude that caloric 
restriction not only reduces obesity, but also increases longevity by reducing oxidative 
stresses that cause age-associated diseases (Weindruch & Sohal, 1997). In contrast, 
restricting calories may be difficult and/or ineffective for many obese older people 
because obesity is also influenced by genetics, social class, and environmental 
characteristics, such as the type of food readily available in the American culture 
(Brownell & Rodin, 1994).   
 Research on the effectiveness of dieting for reducing body weight in elders is 
inconclusive. Many dieting studies have been conducted in university and clinical 
settings but few have followed patients for more than one year to look at long-term 
maintenance of body weight (Brownell & Rodin, 1994). There are no studies on the 
success, or lack of success, of the vast majority of people—perhaps as many as 80-95% 
of dieters—who diet on their own, using books, magazines, diets given to them by others, 
or by enrolling in commercial weight loss programs (Brownell & Rodin, 1994). In 
addition to the lack of empirical evidence that dieting can permanently reduce obesity in 
older adults, some authors warn of the danger that an elder who is encouraged to diet may 
not eat sufficient nutrients to maintain health (Expert Panel on the Identification, 
Evaluation, and Treatment of Overweight and Obesity in Adults, 1998). Those who have 
little money, difficulties in cooking and eating, or problems getting to the store might be 
particularly susceptible to malnutrition if encouraged to reduce their caloric intake 
without understanding the need for good food choices and vitamin supplementation.  
 Clearly, obesity is serious risk factor for mortality from many causes, including 
CVD.  However, it is less clear what should, or can, be done to reduce obesity in elders. 
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Certainly, engaging in physical activity and moderate caloric intake throughout life might 
prevent obesity in many individuals.  However, once a person is over age 65, obesity may 
be the most difficult CVD risk factor to change. The best course of action for obese older 
adults is modest modification of diet accompanied by walking or other enjoyable exercise 
(Jensen & Rogers, 1998). Even if obesity cannot be substantially reduced, the benefits of 
small weight losses should not be ignored. There is evidence that small reductions in 
body weight may improve blood pressure and blood lipids, and may be easier to maintain 
than major weight losses (Brownell & Rodin, 1994). 
Stress 
 Discussion about stress as a risk factor for CVD continues regardless of the fact 
that the American Heart Association asserts that available data do not support its role as 
an independent risk factor for CVD. Investigators have explored the relationship between 
CVD and stress since Sir William Osler, the father of cardiology, spoke of the 
relationship in 1897. Osler said: “In the worry and strain of modern life, arterial 
degeneration is not only very common but develops often at a relatively early age”  (cited 
in Ulmer, 1996).  
 Stress research is plagued by problems of definition and measurement. Everyone 
feels stress, but the amount perceived and the manner in which individuals respond to it 
differs. In spite of these difficulties, investigators in this area have successfully identified 
five specific psychosocial stressors associated with CVD risk: 1) depression (Frasure-
Smith, 1993), 2) anxiety (Kawachi, Sparrow, Vokonas & Weiss, 1994), 3) personality 
factors and character traits (Jorgensen, Johnson, Kolodziej, & Schreer, 1996; Mittleman  
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et al., 1995), 4) social isolation (Case et al., 1992), and 5) chronic life stress such as low 
income (Williams et al., 1992).  
 Two main mechanisms—behavioral and pathophysiological—underlie the 
relationship between these stressors and CVD (Rozanski, Blumenthal, Kaplan, 1999). 
The behavioral explanation proposes that stress contributes to unhealthy behavioral 
patterns such as smoking and a poor diet. The pathophysiological mechanism links stress 
and sympathetic nervous system activation with endothelial dysfunction, 
hypercortisolemia, arrhythmogenesis, platelet dysfunction, and increases in blood 
viscosity, coronary vasoconstriction, and atherosclerosis (Rozanski, et al, 1999). Specific 
endocrine abnormalities, including sensitization of the hypothalamo-pituitary-adrenal 
(HPA) axis, have been shown to result from stress as well. Bjorntorp (1997) suggests that 
stress and some of the behavioral responses to it (e.g., smoking, alcohol consumption) 
aggravate these endocrine responses and result in visceral fat accumulation, insulin 
resistance, and hyperinsulinemia.  
 Presumably, if stress is a risk factor for CVD, its effects accumulate over a 
lifetime. Perhaps this is why little of the stress research focuses on elders. Cardiac and 
vascular reactivity have been found to be positively associated with increasing age and 
the presence of hypertension (Jennings et al., 1997). Some have suggested that systolic 
blood pressure responsiveness to stress may increase with age in women but not men 
(Steptoe, Fieldman, Evans, & Perry, 1996). Aside from these few studies, little is known 
about how stress influences CVD in elders. 
 Perhaps a more productive way of examining the potential effects of stress in 
elders may be to examine the specific stressors thought to be associated with CVD 
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outcomes. Of the five stressors noted previously, depression, long-standing personality 
traits, social isolation, and chronic life stresses such as poverty may be particularly 
important to elders. Intervention trials on these topics are rare in the older population. 
The little research that has been conducted with elders typically focuses on individuals 
who already have CVD, perhaps because it is challenging to find a sample in the older 
age groups without some form of preexisting CVD. 
 Descriptive studies in the area of social isolation abound, but few intervention 
studies have been conducted with elders. Frasure-Smith (1991) conducted a randomized 
clinical trial in which concerned and supportive attention was provided when stress levels 
rose during the first year after a myocardial infarction. When the sample of 453 men was 
divided by stress level, the support intervention reduced both risk of cardiac death and 
recurrence of myocardial infarction in those in the high-stress group.  
Personality factors represent another stressor that could lead to CVD, regardless 
of age. Stress management interventions aimed at addressing personality characteristics 
have been effective. For example, the Recurrent Coronary Prevention Project enrolled 
1000 Type A men after myocardial infarction. A behavioral modification intervention 
focused on time, urgency, and hostility reduced Type A behavior and decreased the rate 
of recurrent cardiac events 45% over a three year interval (Friedman, Thoresen, Gill, et 
al, 1986).  
 In summary, stress seems logical as a risk factor for CVD, but the literature is 
inconclusive. The intervention trials available suggest that modifying stressors in elders 
with CVD may prevent recurrent cardiac events. Continued research is needed to answer 
questions about the cumulative effects of stress, the stressors most relevant to elders, and 
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the effectiveness of various interventions intended to reduce stress. At this point, so little 
research has been conducted with the elderly population that it is not clear whether efforts 
to reduce stress in elders would be worth the effort in terms of CVD prevention. 
Discussion 
This article has examined the risk factors for CVD among elders. The accepted, 
major lifestyle risk factors for CVD were explored as well as the popular but debated risk 
factor, stress. We contend that CVD among elders is ubiquitous but not inevitable. 
Quality, and perhaps quantity, of life may be enhanced if efforts are expanded to modify 
known CVD risks among elders.  
Risk factors for CVD in elderly persons are often not addressed by clinicians. 
Perhaps some believe that elders cannot make behavioral changes late in life. Rowe 
(1999) notes that the neglect of health promotion late in life seems to be based on two 
myths. “The first myth is that the increased risk of disease in older persons reflects 
‘normal’ aging, which is seen as an inevitable, intrinsic process that is largely genetically 
determined. The second myth is that the aged body has little plasticity and cannot 
respond to lifestyle changes. Both myths have been disproved.” (p. 720-1). Beliefs such 
as these have been termed “ageism” (Butler, 1990).  
In fact, attempts to modify certain risk factors may be more productive in elders 
than in younger adults. Adoption of a healthier lifestyle late in life can increase active life 
expectance, decrease disability, and reduce health care costs (Vita, Terry, Aubert & Fries, 
1998; Russell, 1998). Research on the various risk factors suggests that efforts to modify 
HTN, smoking, abnormal blood lipids, and exercise have been successful in elders. 
Modifying obesity in the aging population is more challenging, but weight reduction has 
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far-reaching benefits in simultaneous reduction of other risk factors for CVD.  
How can elders be helped to successfully reduce their risks for CVD? Clearly, 
ageist attitudes that elders cannot successfully change behavioral habits, or that changes 
made by elders have little impact on CVD outcomes must be rejected.  However, 
questions remain even once the challenge of helping an elder reduce the risk of CVD has 
been accepted.  For example, how can one identify those patients who are likely to 
expend the effort needed to make lifestyle changes? Which behavioral changes will 
produce the most benefit in reduced risk of CVD?  
The first issue, identification of elders who will undertake the job of changing a 
lifetime habit in order to reduce CVD risk, depends on recognizing when a person is 
ready to change (Prochaska, DiClemente, & Norcross, 1992). Research has shown that 
there are two moments when elderly persons are particularly willing to start work on 
changing CVD risk factors: a) when they are hospitalized or b) when they recognize that 
physical symptoms, such as shortness of breath or fatigue, are caused by CVD risk 
factors, not “normal” aging. Clinicians who recognize a person’s readiness to take action 
can introduce a program of risk reduction specifically designed to help that individual 
make behavioral changes. Clinicians can assess for readiness to change by asking open-
ended questions about lifestyle and perceptions of symptoms. Such discussions may open 
the door for important lifestyle changes and would represent a significant improvement 
over current practice. For example, 50% of older smokers in one survey reported that 
they had never been told to quit smoking by their physicians (Rich, 1999). 
Historically, some clinicians believed that lifestyle change was so difficult that 
only one change could be implemented at a time. More recently, clinicians have 
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developed effective comprehensive programs aimed at modifying several risk factors 
simultaneously in order to prevent CVD from occurring or recurring (Ornish et al., 1998). 
For example, nurse-run clinics that focused on preventing recurrence of acute events in 
patients with CVD were added to 19 general medical practices in northeast Scotland. The 
comprehensive program at the clinics resulted in significant improvements in blood 
pressure, lipid levels, physical activity, and dietary management, although no effect was 
observed in smoking cessation (Campbell et al., 1998). Findings such as these 
demonstrate the utility of working with elders to modify the aggregate of behaviors that 
put them at risk for CVD. The risk factors of CVD are so interconnected that 
modification of several risks will have more benefit than merely changing one behavior. 
 The research literature supports several clinical interventions that have proven 
efficacious in helping elders reduce one or more of the five major CVD risk factors.  
Hypertension can be treated with a combination of lifestyle changes, such as weight 
reduction, physical activity, and dietary changes, in addition to medication. 
Unfortunately, research shows that younger patients receive medication for HTN more 
often than do elderly persons although elders benefit equally from aggressive therapy. 
Likewise, abnormal blood lipids can be effectively controlled by medications, especially 
for high-risk elders who already have CVD. However, dietary changes, such as a low-fat 
diet, may control abnormal blood lipids in many. Three of the major risk factors for 
CVD—smoking, inactivity, and obesity—require behavioral changes by the patient, 
rather than prescription of medications, although smoking cessation can be facilitated by 
nicotine replacement therapy.  
The clinical interventions suggested in the body of the article are based on 
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research, but there are several gaps in our knowledge of CVD risks in elders that need to 
be addressed in future studies. For example, there are few data about the efficacy of lipid 
lowering medications in older patients, so those instituting this therapy in elders are 
basing their decision on positive results in younger populations. There is a similar lack of 
evidence in the literature for the safety and efficacy for elders of nicotine patches to aid in 
smoking cessation. More research data on the distinctions between blood pressure 
changes that may occur as part of aging and pathological increases in blood pressure 
would help to settle the disagreement that exists among clinicians about what levels of 
blood pressure elevation require medication. Another area for research is determining the 
type of physical activity that produces the most benefits for weight reduction in elders. 
For example, resistance exercises may provide as much, or more, energy expenditure 
than endurance exercises in elders (Ortega & Andres, 1998) but more data are needed to 
confirm this observation. Most importantly, more studies on successful interventions to 
reduce CVD risk factors should be undertaken and those studies should include 
participants who are over age 65. Though there is little reason to believe that treatments, 
programs and counseling that change the risk profiles of younger adults will not be 
equally useful to help elders reduce their risks of CVD, there is currently little evidence 
to support this position.  More empirical data may result in better, more accurate, and 
more frequent treatment of CVD risk factors in elders in the future. 
The Ministers of Health of Member States in the Americas recently adopted a 
resolution focusing on the impact that population aging will have on health care, family 
caregiving, and the distribution of resources throughout the lifespan. They concluded that 
“the greatest challenge of the millennium will be to keep aging populations active and 
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free from disabling diseases for as long as possible and that active and healthy aging 
depends to a large extent on health promotion” (Hegyeli, 1999). Cardiovascular disease is 
currently the primary cause of death and disability in the United States and a 
disproportionate number of Americans who are over age 65 are hospitalized each year for 
CVD. Yet, many older adults are inadequately treated with medications to reduce the risk 
of CVD, or are not encouraged to adopt lifestyle modifications that could reduce the risk 
of CVD and increase health-related quality of life. Patients at risk for CVD must be 
encouraged to reduce those risks, regardless of age.  
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